Statistics
Total Visits
| Views | |
|---|---|
| Interactions of N-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-2-aryl-2-yl-acetamides and 1-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-3-aryl-2-yl-ureas with dopamine D-2 and 5-hydroxytryptamine 5HT(1A) receptors | 249 |
Total Visits Per Month
| November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
|---|---|---|---|---|---|---|---|
| Interactions of N-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-2-aryl-2-yl-acetamides and 1-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-3-aryl-2-yl-ureas with dopamine D-2 and 5-hydroxytryptamine 5HT(1A) receptors | 13 | 10 | 1 | 21 | 6 | 1 | 0 |
File Visits
| Views | |
|---|---|
| 972.pdf | 2 |
Top country views
| Views | |
|---|---|
| United States | 133 |
| Sweden | 14 |
| Serbia | 9 |
| Poland | 2 |
| Russia | 2 |
| Finland | 1 |
| Italy | 1 |
| Japan | 1 |
| Moldova | 1 |
Top cities views
| Views | |
|---|---|
| Ashburn | 115 |
| Belgrade | 9 |
| Warsaw | 2 |
| Arezzo | 1 |
| Des Moines | 1 |
| Klaukkala | 1 |
| Tokyo | 1 |